As the population grows older worldwide, the challenge is not only to extend limits of lifespan but also to maintain normal activities of daily living in the later years of life. Cognitive dysfunction or dementia is a critical issue because it can cause a cascade of sequela such as falls, loss of independence, need for hospital care, and even cardiovascular-or noncardiovascular-related death. 1 Efforts to prevent cognitive dysfunction have become a major public health goal. To do so, an understanding of the risk factors contributing to cognitive dysfunction, and identification those at younger age who may be at risk for developing cognitive dysfunction, are becoming top priorities.
been well established. [1] [2] [3] Additionally, ambulatory BP measures, in particular nocturnal BP abnormalities (i.e., higher absolute values and less nocturnal BP dipping), have been reported to be associated with cognitive dysfunction; [4] [5] [6] [7] [8] [9] [10] most of these data were obtained in cross-sectional analyses for older populations, raising the possibility that comorbidities (e.g., cerebrovascular diseases with or without symptoms) could have affected both participants' nocturnal BP and cognition. 11, 12 To our knowledge, no studies have examined whether nocturnal BP measured during young adulthood is associated with cognitive function in midlife, and the association is independent of long-term office BP values during follow-up. The Coronary Artery Risk Development in Young Adults (CARDIA) Study provides a unique opportunity to examine these issues, as CARDIA enrolled only young adults (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) years) with few comorbidities.
Using CARDIA data, we assessed whether nocturnal BP levels and BP dipping in young adults are associated with measures of cognitive function 20 year later in midlife, independent of long-term office BP values during follow-up.
METHODS

Overall design
The CARDIA Study is a multicenter longitudinal cohort of 5,115 young adults initially ages 18-30 years in [1985] [1986] (see Supplementary Data). Black and white adults, who were healthy at enrollment, were recruited from 4 US cities and underwent baseline examination (Year 0: Y 0 ) and followup examinations at Y 2 , Y 5 , Y 7 , Y 10 , Y 15 , Y 20 , and Y 25 . The CARDIA study and this CARDIA ambulatory blood pressure monitoring (ABPM) substudy were approved by the appropriate institutional review boards, and informed consent was obtained from each study participant.
As described previously, 13 ABPM was performed in Y 5 at 1 site (Birmingham, AL). A total of 316 people (147 men and 169 women; 112 whites and 204 blacks), selected randomly at the Birmingham center, completed this substudy.
BP and other measurements
The methods in office BP measures are shown in Supplementary Data. The baseline BP (Y 5 ) and cumulative exposure of BP through Y 5 to Y 25 (Y 5-25 ; mm Hg × year; the formula is shown in Supplementary Figure S1 ) were used as adjustment factors.
At Y 5 , ABPM was performed over a 24-hour period with a Suntech Accutracker II (Suntech Medical, Morrisville, NC), 13 using an appropriately sized cuff inflated approximately every 20 minutes during the day (6:00 am-10:00 pm) and every 30 minutes during the night (10:00 pm-6:00 am). As done in a previous report of CARDIA ABPM, 13 we defined daytime BP as average BP between 10:00 am and 10:00 pm and nocturnal BP between 12:00 am and 6:00 am. The magnitude of nocturnal BP dipping was calculated as (nocturnal SBP-daytime SBP) × 100/daytime SBP. 14, 15 Nocturnal BP dipping calculated by SBP is strongly correlated with that calculated by diastolic BP (DBP; r = 0.6, P < 0.0001). Most of the prior literature used SBP to calculate nocturnal BP dipping, 14,15 so we did as well. We assessed "poor sleep quality" during the ABPM session as any report of being unable to fall asleep, being awakened ≥5 times, or not being able to sleep at all. 13 Data on other factors including education, physical activity, and laboratory values were collected using standardized protocols and quality control across study centers and examinations (see Supplementary Data).
Cognitive function assessment
A battery of standardized tests to measure cognitive function was performed at the Y 25 examination. 16 Training and certification of CARDIA technicians for measurement of cognitive function were performed centrally by CARDIA investigators and coordinating center data quality assurance staff. The Stroop test evaluates the ability to view complex visual stimuli and to respond to one stimulus dimension while suppressing the response to another dimension, an executive skill largely attributed to frontal lobe function. 17 The interference score provides a measure of how much additional executive processing is needed to respond to an incongruent trial; thus, a higher interference score indicates worse performance on the task. Each trial was scored by summing the number of errors and the time required to complete each trial. An interference score was calculated by subtracting the score on the incongruent trial from the second congruent trial. The Digit Symbol Substitution Test (DSST), a subtest of the Wechsler Adult Intelligence Scale (3rd edition), assesses an array of cognitive domains, most prominently visual motor speed, sustained attention, and working memory. The range of scores is 0-133, with increasing scores indicating better performance. The Rey Auditory Verbal Learning Test (RAVLT) assesses the ability to memorize and to retrieve words (verbal memory) after several presentations of the word list immediately one after another, and then after a delay of 10 minutes. Results from the long-delay (10 minutes) free recall were used in analyses. The range of scores is 0-15, with increasing scores indicating better performance.
Analysis
Among 316 participants, we excluded 14 participants with missing data on daytime BP or nocturnal BP, 60 participants who did not attend the follow-up examination at Y 25 Table S1 ).
Statistical analyses were performed using SAS software version 9.3 (SAS Institute Inc, Cary, NC). Demographic and clinical characteristics of the participants across quartiles were tested by analysis of variance or chi-squared test. Unadjusted and multivariable-adjusted linear regression models were used to assess the association of nocturnal BP with cognitive function measures. Because there is no standard definition on physiological nocturnal BP dipping in young adults, we defined Quartile 3, centered on −10% nocturnal BP dipping, as the reference group. This approach was used in a previous report of CARDIA ABPM substudy to test the association of nocturnal BP with coronary calcium. 13 Our analyses were performed with sequential adjustment. In the first step, we carried out unadjusted analyses (Model 1). In the second step, we adjusted for demographic covariates including age (Y 5 ), sex, race (black and white), and educational attainment in years (Model 2). In the last step, we further adjusted for the clinical characteristics at Y 25 (i.e., body mass index, smoking, alcohol, physical activity, glucose and lipid parameters, use of antihypertensive drugs, and incidence of stroke) plus office BP at Y 5 (Model 3), daytime BP at Y 5 (Model 4), or cumulative exposure of office BP (Y 5-25 ; Model 5). Statistical significance was defined by a P value of <0.05 on 2-sided tests.
RESULTS
Of the 224 participants, 45% were men, 63% were African American, their mean age was 30 years, and 0.5% were treated with antihypertensive drugs at baseline. Table 1 provides the demographic and clinical characteristics of the included participants stratified by the quartile of nocturnal SBP dipping. By definition, Quartile 1 showed the most nocturnal SBP dipping (−39.3% to −16.9%), and Quartile 4 (−7.7% to +56.4%) showed the least. The mean time of BP measures was 46 ± 10 times in daytime and 14 ± 2 times in nighttime. Across quartiles, age, sex, and educational attainment were similar. The proportion of African Americans was higher in the higher quartiles of nocturnal BP dipping. Supplementary  Tables S2-S6 show the associations between nocturnal BP Abbreviations: ABPM, ambulatory blood pressure monitoring; Q, quartile; SBP, systolic blood pressure. Data are expressed as the means ± standard deviation or percentage. P values were obtained by analysis of variance or chi-squared test among quartile groups. The magnitude of nocturnal SBP dipping was calculated as (nocturnal SBP-daytime SBP) × 100/daytime SBP. Poor sleep quality was defined as any report of being unable to fall asleep, being awakened ≥5 times, or not being able to sleep at all during the ABPM session. Statistical significance was defined as P < 0.05. and clinical characteristics. Men, blacks, and higher body mass index were associated with higher nocturnal BP. No difference was observed in nocturnal BP between those with or without poor sleep quality. Office and ambulatory BP values across quartiles are shown in Table 2 . Cumulative exposure of office SBP and DBP during follow-up was higher in Quartiles 2-4 vs. 1 of nocturnal dipping, but the trend was not statistically significant (P = 0.08).
Among participants, mean ± standard deviation scores on the Stroop test, DSST, and RAVLT were 25.9 ± 11.6 seconds + errors (range = Table 3 shows unadjusted and multivariable-adjusted linear regression models examining the associations of nocturnal BP with cognitive function. Quartile 4 (vs. Quartile 3) was associated with worse Stroop and DSST scores (Model 1 in Table 3 ). Nocturnal SBP dipping, when assessed as a continuous variable, was not associated with cognitive function. Higher nocturnal DBP was associated with worse Stroop test scores, and worse DSST and RAVLT scores (Model 1 in Table 3 Table 3 ; all P ≥ 0.09). When we adjusted for the presence of poor sleep quality during ABPM as covariates, the overall findings were similar (Supplementary Table  S7 ). When we used clinical characteristics at Y 5 instead of those at Y 25 as adjusted factors, the results were mostly similar (Supplementary Table S8 ).
There were no significant interactions between race and any of the nocturnal BP variables (nocturnal SBP dipping, nocturnal SBP levels, or nocturnal DBP levels) in associations with the Stroop test, DSST, and RAVLT scores (all P ≥ 0.15).
DISCUSSION
Among healthy young adults (mean age 30 years and mean office BP 109/73 mm Hg), we show that nocturnal SBP dipping less than 7.7% (compared with that between 13.1% and 7.8%) and higher nocturnal DBP levels were associated with lower executive function (i.e., Stroop test) 20 years later in midlife. The associations were independent of multiple measures of office BP during long-term follow-up.
The finding in this study of a stronger association of nocturnal BP than office or daytime BP with cognitive function raises questions about mechanisms. Some plausible, albeit speculative, explanations are suggested. First, cerebrovascular responsiveness is reduced during sleep, and cerebral blood flow decreases by approximately 30% at least during nonrapid eye movement stages. 18, 19 The neurovascular unit may be particularly vulnerable to BP burden during sleep. 20 Second, in terms of physical and mental activity as well as body position, the nocturnal BP compared with office or daytime BP is better standardized without being influenced by environmental stimuli. 14, 15 Third, nocturnal BP compared with office or daytime BP could reflect concurrent pathophysiology, such as sympathovagal imbalance, volume retention, impaired salt excretion, and disturbed breathing during sleep. [21] [22] [23] [24] [25] Obstructive sleep apnea in particular could affect both nocturnal BP increase and cognitive dysfunction via nocturnal hypoxia and resultant sympathetic nerve activation. 24, 25 Nocturnal BP dipping is further affected by sporadic factors, such as physical activity during daytime and orthostatic BP changes. 14, 15 From our data, whether less nocturnal SBP dipping and higher nocturnal DBP in young adults are simply markers of concurrent pathophysiology or related in a causal pathway to pathogenesis in cognitive dysfunction remains uncertain and promotes us to further explore whether improving nocturnal BP abnormalities in young adults can prevent lower cognitive function in those middle-aged or over. We found that nocturnal SBP was not associated with cognitive function after multivariable adjustment. The relative importance of DBP and SBP to cardiovascular disease risk differs with aging; DBP is more predictive for cardiovascular disease events than SBP in younger adults. 26 Among adolescents ages 7-20 years, higher 24-hour DBP rather than 24-hour SBP, even within the normotensive range, was associated with impaired cerebrovascular reactivity. 27 Our findings may complement the data, by showing a prospective association of higher nocturnal DBP in young adulthood with lower cognitive function in midlife.
Nocturnal SBP dipping and nocturnal DBP level were associated with Stroop score, a test reflecting white matter integrity in the frontal lobe, 17, 28 but not with RAVLT and DSST scores. Our sample size was small, so the null associations of the RAVLT and DSST tests might be a consequence of lack of power. However, the associations of higher BP with white matter disease have been shown to be greater for the frontal lobe than other areas. 2, 20, 29 The exact mechanism of the regional specificity remains unclear, but the type and size of vessels, myogenic reactivity, vasodilator capacity, neurovascular units, and innervation of the cerebral blood vessels may vary by brain location. 3, 20 Different components of ambulatory BP are known to affect different parts of cerebral structure and function. 4, 8, 10 Among older individuals, higher nocturnal SBP and less nocturnal SBP dipping were specifically associated with frontal lobe atrophy and subsequently lower executive function. 8, 10 Further investigations using brain magnetic resonance imaging may allow us to understand the underlying pathways (e.g., vascular dysfunction, brain atrophy, or impaired brain integrity) between higher nocturnal BP and cognitive dysfunction, and whether brain regional specificity exists in relation to nocturnal BP.
In our study, 82% of those with the least nocturnal BP dipping (i.e., Quartile 4) were African Americans. African Americans are known to have higher nocturnal BP and less dipping compared with whites. [30] [31] [32] The mechanisms remain uncertain, but salt sensitivity, abnormal autonomic function, socioeconomic factors, and psychological factors have each been associated with altered diurnal BP variation 14, 15 and are more common in African Americans compared with whites. 21, 30, [32] [33] [34] [35] [36] Our sample size was not large enough to allow robust race-specific analyses, but we observed no significant interactions between race and any of the nocturnal BP variables in association with cognitive function.
The major strengths of this study include long-term, repeated examinations of well-characterized participants from young adulthood to middle age and application of a comprehensive standardized cognitive test battery. However, there are limitations. First, we could not assess changes in cognitive function from baseline to follow-up, and we cannot conclude whether the low cognitive function scores reflect cognitive decline. Further CARDIA examinations including cognitive function would enable us to explore the time course of cognitive function in participants with abnormal nocturnal BP. Second, although our findings were statistically significant, whether nocturnal BP measurement in young adults, particularly in those who had normal office BP with minimum cardiovascular risks, is clinically meaningful remains uncertain. Further investigations are warranted, including analyses of the cost-effectiveness, availability, and invasiveness (e.g., with respect to sleep disturbances, discomfort, and restrictions in daily activities) of ABPM, as well as analyses identifying clinical characteristics (e.g., risk factors) in which ABPM is recommended. Third, we have only a single measurement of ABPM, and the reproducibility was limited. Some participants might have had sleep deprivation during the overnight BP monitoring. We adjusted for sleep quality and the results were similar. Also, it can be difficult to discern the transition from daytime to nocturnal BP measurements (i.e., bedtime), though several studies similarly used fixed clock-time intervals. 14, 15 Fourth, a number of participants from the original cohort were excluded, so there is a potential selection bias. Fifth, we did not assess what classes of antihypertensive drug were used in this study, and some of these drugs can affect cognitive function. 37 Finally, our sample consists of black and white adults, so our findings cannot be generalized to other race/ethnic groups. Among healthy young adults, less nocturnal SBP dipping and higher nocturnal DBP were associated with lower executive function 20 years later in midlife. Our results may help to identify young adults at risk for developing lower cognitive function in midlife. Replications in different studies/ Bold values suggest significant associations. β means standardized regression coefficient, and R 2 means a measure for the model prediction. Quartile of nocturnal SBP dipping consists of Q1 (−39.3% to −16.9%), Q2 (−16.8% to −13.2%), Q3 (−13.1% to −7.8%), and Q4 (−7.7% to +56.4%). A higher score of the Stroop test indicates worse performance on the task, and a lower score of DSST and RAVLT indicates worse performance on the task. As adjusted factors, each model includes some covariates as follows: Model 2 includes demographic variables (age at baseline, sex, race, and education); Model 3 includes demographic variables + clinical characteristics at Y 25 (body mass index, smoking, drinking, physical activity, fasting glucose, total cholesterol/high-density lipoprotein, use of antihypertensive drugs, incidence of stroke) + office BP at Y 5 ; Model 4 includes demographic variables + clinical characteristics at Y 25 + daytime BP at Y 5 ; Model 5 included demographic variables + clinical characteristics at Y 25 + cumulative exposure of office BP (Y 5-25 ); statistical significance was defined as P < 0.05. *P < 0.05; **P < 0.01; ***P < 0.001.
cohorts with larger samples size are warranted. Continued follow-up in CARDIA may allow us to discern the association of nocturnal BP in young adulthood with aging-related cognitive decline and dementia through older age. Such evidence may help to direct potential strategies for preventing lower cognitive function in those middle-aged or over.
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